What is the Supriya Lifescience PE ratio today?
Supriya Lifescience's PE ratio is 35.3 at the 29 October 2026 close (₹869.30 a share): a market capitalisation of ₹6,997 crore divided by consolidated net profit of ₹198 crore over the last four quarters (Q2 FY26 to Q1 FY27).
What is the Supriya Lifescience net worth?
Supriya Lifescience's net worth — shareholders' equity in its consolidated balance sheet — was ₹1,198 crore on 31 March 2026, up 20.2% from ₹997 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹6,997 crore at the 29 October 2026 close.
What is the Supriya Lifescience dividend yield?
Supriya Lifescience's dividend yield is 0.12% at the 29 October 2026 close: dividends of ₹1 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹869.30. They were ₹1 on 4 September 2026.
What is the Supriya Lifescience PB ratio (price to book value)?
Supriya Lifescience's price-to-book (PB) ratio is 5.84 at the 29 October 2026 close: a market capitalisation of ₹6,997 crore divided by shareholders' equity (book value) of ₹1,198 crore on 31 March 2026. That is a book value of ₹148.81 per share against a share price of ₹869.30.
What is the Supriya Lifescience shareholding pattern?
On 30 September 2026, Supriya Lifescience's shares were held by promoters 68.30%, foreign portfolio investors (FII/FPI) 6.44%, domestic institutions (DII) 5.47% (including mutual funds at 1.28%) and retail and other non-institutional investors 19.79%. Over the year, FII holding was up 0.98 percentage points from 5.46% and DII holding was up 0.25 percentage points from 5.22%.
What is the Supriya Lifescience free cash flow?
In FY25, Supriya Lifescience generated ₹165 crore of cash from operations and spent ₹162 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹2.3 crore. In FY24 it was −₹32.3 crore.
What is the Supriya Lifescience market cap?
Supriya Lifescience's market capitalisation was ₹6,997 crore at the 29 October 2026 close: 8.05 crore shares at ₹869.30 each.
Is Supriya Lifescience debt free?
Yes. Supriya Lifescience had no borrowings on 31 March 2026 (consolidated balance sheet), and it held ₹78.9 crore of cash, bank balances and current investments.
What is the Supriya Lifescience dividend in 2026 and its record date?
In 2026, Supriya Lifescience has declared one dividend: ₹1 with record date 4 September 2026.
What is the Supriya Lifescience debt to equity ratio?
Supriya Lifescience's debt-to-equity ratio was 0.00 on 31 March 2026: no borrowings against total equity of ₹1,198 crore. A year earlier, on 31 March 2025, it was 0.00.
What is the Supriya Lifescience book value per share?
Supriya Lifescience's book value per share was ₹148.81 on 31 March 2026: shareholders' equity of ₹1,198 crore divided by the 8.05 crore shares in issue. The share price at the 29 October 2026 close was ₹869.30.
What is the Supriya Lifescience promoter holding?
Promoters held 68.30% of Supriya Lifescience on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
What are the Supriya Lifescience latest quarterly results?
Supriya Lifescience's latest results are for Q1 FY27 (April–June 2026), filed on 13 August 2026: consolidated net profit ₹24 crore, down 30.9% from ₹34.8 crore in Q1 FY26; revenue from operations ₹190 crore, up 30.8% year on year.
When are the Supriya Lifescience next results?
Supriya Lifescience has not yet announced the date of its Q2 FY27 results (July–September 2026); under SEBI's listing rules (Regulation 33) they are due by 14 November 2026.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.
